Skip to main content

Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.

Publication ,  Journal Article
Montefiori, DC; Collman, RG; Fouts, TR; Zhou, JY; Bilska, M; Hoxie, JA; Moore, JP; Bolognesi, DP
Published in: J Virol
March 1998

Human immunodeficiency virus type 1 (HIV-1) uses a variety of chemokine receptors as coreceptors for virus entry, and the ability of the virus to be neutralized by antibody may depend on which coreceptors are used. In particular, laboratory-adapted variants of the virus that use CXCR4 as a coreceptor are highly sensitive to neutralization by sera from HIV-1-infected individuals, whereas primary isolates that use CCR5 instead of, or in addition to, CXCR4 are neutralized poorly. To determine whether this dichotomy in neutralization sensitivity could be explained by differential coreceptor usage, virus neutralization by serum samples from HIV-1-infected individuals was assessed in MT-2 cells, which express CXCR4 but not CCR5, and in mitogen-stimulated human peripheral blood mononuclear cells (PBMC), where multiple coreceptors including CXCR4 and CCR5 are available for use. Our results showed that three of four primary isolates with a syncytium-inducing (SI) phenotype and that use CXCR4 and CCR5 were neutralized poorly in both MT-2 cells and PBMC. The fourth isolate, designated 89.6, was more sensitive to neutralization in MT-2 cells than in PBMC. We showed that the neutralization of 89.6 in PBMC was not improved when CCR5 was blocked by having RANTES, MIP-1alpha, and MIP-1beta in the culture medium, indicating that CCR5 usage was not responsible for the decreased sensitivity to neutralization in PBMC. Consistent with this finding, a laboratory-adapted strain of virus (IIIB) was significantly more sensitive to neutralization in CCR5-deficient PBMC (homozygous delta32-CCR5 allele) than were two of two SI primary isolates tested. The results indicate that the ability of HIV-1 to be neutralized by sera from infected individuals depends on factors other than coreceptor usage.

Duke Scholars

Published In

J Virol

DOI

ISSN

0022-538X

Publication Date

March 1998

Volume

72

Issue

3

Start / End Page

1886 / 1893

Location

United States

Related Subject Headings

  • Virology
  • Receptors, CXCR4
  • Receptors, CCR5
  • Neutralization Tests
  • Middle Aged
  • Macrophage Inflammatory Proteins
  • Leukocytes, Mononuclear
  • Humans
  • HIV-1
  • HIV Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Montefiori, D. C., Collman, R. G., Fouts, T. R., Zhou, J. Y., Bilska, M., Hoxie, J. A., … Bolognesi, D. P. (1998). Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J Virol, 72(3), 1886–1893. https://doi.org/10.1128/JVI.72.3.1886-1893.1998
Montefiori, D. C., R. G. Collman, T. R. Fouts, J. Y. Zhou, M. Bilska, J. A. Hoxie, J. P. Moore, and D. P. Bolognesi. “Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.J Virol 72, no. 3 (March 1998): 1886–93. https://doi.org/10.1128/JVI.72.3.1886-1893.1998.
Montefiori DC, Collman RG, Fouts TR, Zhou JY, Bilska M, Hoxie JA, et al. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J Virol. 1998 Mar;72(3):1886–93.
Montefiori, D. C., et al. “Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.J Virol, vol. 72, no. 3, Mar. 1998, pp. 1886–93. Pubmed, doi:10.1128/JVI.72.3.1886-1893.1998.
Montefiori DC, Collman RG, Fouts TR, Zhou JY, Bilska M, Hoxie JA, Moore JP, Bolognesi DP. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J Virol. 1998 Mar;72(3):1886–1893.

Published In

J Virol

DOI

ISSN

0022-538X

Publication Date

March 1998

Volume

72

Issue

3

Start / End Page

1886 / 1893

Location

United States

Related Subject Headings

  • Virology
  • Receptors, CXCR4
  • Receptors, CCR5
  • Neutralization Tests
  • Middle Aged
  • Macrophage Inflammatory Proteins
  • Leukocytes, Mononuclear
  • Humans
  • HIV-1
  • HIV Infections